Nanobiotix SA / VDI/VDE / Technik GmbH / BCC Research / Translation Hub / Cambridge Nanomaterials Technology Ltd / ELSA Advisory Group / Key Enabling Technologies / European Nano-Characterization Laboratory / ETPN / Programme / /
Continent
Europe / /
Country
Germany / Switzerland / Italy / Norway / France / United States / United Kingdom / Spain / /
Currency
USD / /
Event
Business Partnership / /
Facility
CEA headquarters / University of Münster / European Nano-Characterization Laboratory / Cranfield University / /
IndustryTerm
supply chain / nano-electronics / biotechnology / non-clinical applications / pharmaceutical and med-tech / biological systems / similar infrastructure / nanomedicine products / imaging / visual tool / large pharmaceutical industries / in vivo imaging / nano-delivery products / manufacturing / pharmaceutical products / communication tools / /
Organization
French Atomic Energy and Alternative Energies Commission / Foresight & Strategy Division / National Institute of Health / CLINAM Foundation / Institut National Agronomique / Executive Board of the ETP Nanomedicine / Minatec Innovation Center / European Foundation for Clinical Nanomedicine Angemeldet / European Parliament / European Foundation for Clinical Nanomedicine / University of Münster / European Medicines Agency / Cranfield University / European Commission / Ecole Nationale / US Nano-Characterization Lab / European Union / /
Person
Olivier Fontaine / Klaus-Michael Weltring / Bojan Boskovic / Patrick Boisseau / /
Position
Editor / multidisciplinary engineer / Manager / mediator / head / Director Bioanalytikmuenster / deputy-coordinator / leader / Chairman / coordinator / Managing Director / molecular biologist / /
TVStation
KETs / /
Technology
European Technology / biotechnology / regenerative medicine / /
Eur. J. Nanomed. 2012;4(2-4):95–97 © 2012 by Walter de Gruyter • Berlin • Boston. DOI[removed]ejnm[removed]Letter to the Editor NanoMed 2020 – Enabling the European nanomedicine area until 2020